2007 omalizumab for severe persistent allergic asthma (nice)
These Guidelines on the diagnosis and management of asthma were developed by an expert panel commissioned by the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee, coordinated by the Continue Reading →